person · Reporting owner

GARTEN JEFFREY E

Disclosed activity across 4 companies

Tapewire entity: 160267
SEC CIK: 0001181532

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
CARMAX INCKMX · Entity 3604	Director	June 29, 2017	June 30, 2017
UBS ASSET MANAGEMENT HIGH YIELD CREDIT FUNDDHY · Entity 8862	Trustee	February 12, 2019	February 14, 2019
UBS ASSET MANAGEMENT INCOME FUND, INC.CIK · Entity 8817	Director	April 24, 2018	April 30, 2018

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

CARMAX INC

Report date June 29, 2017 · Filed June 30, 2017

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	23,958	Reported balance After 2017-06-29 transaction · row 1 1 source row Row 1 · 2017-06-29 · Grant · Acquired 2,406 · Balance 23,958 F1: These are restricted shares of common stock that will vest on the one-year anniversary of the grant date.

Filing footnotes · ownership attribution and instrument terms

F1: These are restricted shares of common stock that will vest on the one-year anniversary of the grant date.

UBS ASSET MANAGEMENT HIGH YIELD CREDIT FUND

Report date February 12, 2019 · Filed February 14, 2019

This filing explicitly reported no securities owned.

UBS ASSET MANAGEMENT INCOME FUND, INC.

Report date April 24, 2018 · Filed April 30, 2018

This filing explicitly reported no securities owned.

Past disclosures · reporting ended (1)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

AETNA INC /PA/

Report date November 28, 2018 · Filed November 28, 2018

Section 16 reporting ended · disclosed 2018-11-28. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosure context
Common StockSEC Table I · non-derivative	Direct	Reported balance After 2018-11-28 transaction · row 1 1 source row Row 1 · 2018-11-28 · Disposition to issuer · Disposed 12,403.154 · Balance 0 F1: Includes Aetna Common Stock acquired pursuant to dividend reinvestment on August 1, 2018 and November 1, 2018. F2: Converted pursuant to the merger agreement (the "Merger Agreement") between CVS Health Corporation ("CVS Health") and Aetna Inc. ("Aetna") into $145 in cash and 0.8378 shares of CVS Health Common Stock for each share of Aetna Common Stock.
Phantom Stock UnitsSEC Table II · derivative / convertible security	Direct	Reported balance After 2018-11-28 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2018-11-28 · Disposition to issuer · Disposed 24,756 · Balance 0 F3: Previously reported Units granted under the Non-Employee Director Compensation Plan (the "Plan"). These Units were canceled pursuant to the terms of the Plan in exchange for an amount in cash for each Unit equal to the closing price of Aetna Common Stock on the closing date under the Merger Agreement.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	Reported balance After 2018-11-28 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2018-11-28 · Disposition to issuer · Disposed 990 · Balance 0 F4: Previously reported Restricted Stock Units granted under the Plan on May 18, 2018. These Restricted Stock Units were canceled pursuant to the terms of the Plan in exchange for an amount in cash for each Restricted Stock Unit equal to the closing price of Aetna Common Stock on the closing date under the Merger Agreement.

Filing footnotes · ownership attribution and instrument terms

F1: Includes Aetna Common Stock acquired pursuant to dividend reinvestment on August 1, 2018 and November 1, 2018.

F2: Converted pursuant to the merger agreement (the "Merger Agreement") between CVS Health Corporation ("CVS Health") and Aetna Inc. ("Aetna") into $145 in cash and 0.8378 shares of CVS Health Common Stock for each share of Aetna Common Stock.

F3: Previously reported Units granted under the Non-Employee Director Compensation Plan (the "Plan"). These Units were canceled pursuant to the terms of the Plan in exchange for an amount in cash for each Unit equal to the closing price of Aetna Common Stock on the closing date under the Merger Agreement.

F4: Previously reported Restricted Stock Units granted under the Plan on May 18, 2018. These Restricted Stock Units were canceled pursuant to the terms of the Plan in exchange for an amount in cash for each Restricted Stock Unit equal to the closing price of Aetna Common Stock on the closing date under the Merger Agreement.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
November 28, 2018 Filed Nov 28, 2018 16:39 UTC	AETNA INC /PA/ AET · Entity 107289	Disposition to issuerRestricted Stock Units · Derivative	990	Not disclosed	Not disclosed	Disclosure SEC source: 0001122304-18-000172 · edgar.xml · derivative · entry 3 GARTEN JEFFREY E · CIK 0001181532 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 990 shares Expires not disclosed F4 · derivative.exercise_price: Previously reported Restricted Stock Units granted under the Plan on May 18, 2018. These Restricted Stock Units were canceled pursuant to the terms of the Plan in exchange for an amount in cash for each Restricted Stock Unit equal to the closing price of Aetna Common Stock on the closing date under the Merger Agreement. F4 · price: Previously reported Restricted Stock Units granted under the Plan on May 18, 2018. These Restricted Stock Units were canceled pursuant to the terms of the Plan in exchange for an amount in cash for each Restricted Stock Unit equal to the closing price of Aetna Common Stock on the closing date under the Merger Agreement. F4 · derivative.exercise_date: Previously reported Restricted Stock Units granted under the Plan on May 18, 2018. These Restricted Stock Units were canceled pursuant to the terms of the Plan in exchange for an amount in cash for each Restricted Stock Unit equal to the closing price of Aetna Common Stock on the closing date under the Merger Agreement. F4 · derivative.expiration_date: Previously reported Restricted Stock Units granted under the Plan on May 18, 2018. These Restricted Stock Units were canceled pursuant to the terms of the Plan in exchange for an amount in cash for each Restricted Stock Unit equal to the closing price of Aetna Common Stock on the closing date under the Merger Agreement. Read SEC document
November 28, 2018 Filed Nov 28, 2018 16:39 UTC	AETNA INC /PA/ AET · Entity 107289	Disposition to issuerPhantom Stock Units · Derivative	24,756	Not disclosed	Not disclosed	Disclosure SEC source: 0001122304-18-000172 · edgar.xml · derivative · entry 2 GARTEN JEFFREY E · CIK 0001181532 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 24,756 shares Expires not disclosed F3 · derivative.exercise_price: Previously reported Units granted under the Non-Employee Director Compensation Plan (the "Plan"). These Units were canceled pursuant to the terms of the Plan in exchange for an amount in cash for each Unit equal to the closing price of Aetna Common Stock on the closing date under the Merger Agreement. F3 · price: Previously reported Units granted under the Non-Employee Director Compensation Plan (the "Plan"). These Units were canceled pursuant to the terms of the Plan in exchange for an amount in cash for each Unit equal to the closing price of Aetna Common Stock on the closing date under the Merger Agreement. F3 · derivative.exercise_date: Previously reported Units granted under the Non-Employee Director Compensation Plan (the "Plan"). These Units were canceled pursuant to the terms of the Plan in exchange for an amount in cash for each Unit equal to the closing price of Aetna Common Stock on the closing date under the Merger Agreement. F3 · derivative.expiration_date: Previously reported Units granted under the Non-Employee Director Compensation Plan (the "Plan"). These Units were canceled pursuant to the terms of the Plan in exchange for an amount in cash for each Unit equal to the closing price of Aetna Common Stock on the closing date under the Merger Agreement. Read SEC document
November 28, 2018 Filed Nov 28, 2018 16:39 UTC	AETNA INC /PA/ AET · Entity 107289	Disposition to issuerCommon Stock	12,403.154	Not disclosed	Not disclosed	Disclosure SEC source: 0001122304-18-000172 · edgar.xml · nonDerivative · entry 1 GARTEN JEFFREY E · CIK 0001181532 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · shares: Includes Aetna Common Stock acquired pursuant to dividend reinvestment on August 1, 2018 and November 1, 2018. F2 · price: Converted pursuant to the merger agreement (the "Merger Agreement") between CVS Health Corporation ("CVS Health") and Aetna Inc. ("Aetna") into $145 in cash and 0.8378 shares of CVS Health Common Stock for each share of Aetna Common Stock. Read SEC document
May 21, 2018 Filed May 22, 2018 16:06 UTC	AETNA INC /PA/ AET · Entity 107289	Exercise / conversionRestricted Stock Units · Derivative	1,203	Not disclosed	Not disclosed	Disclosure SEC source: 0001122304-18-000095 · edgar.xml · derivative · entry 3 GARTEN JEFFREY E · CIK 0001181532 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,203 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Units convert to Common Stock on a one-for-one basis. F1 · price: Units convert to Common Stock on a one-for-one basis. F4 · derivative.exercise_date: Units granted under the Plan. Subject to terms of the Plan, Units vested in four substantially equal installments on August 18, 2017, November 18, 2017, February 18, 2018, and May 18, 2018, with payment of the Units deferred until May 21, 2018. F4 · derivative.expiration_date: Units granted under the Plan. Subject to terms of the Plan, Units vested in four substantially equal installments on August 18, 2017, November 18, 2017, February 18, 2018, and May 18, 2018, with payment of the Units deferred until May 21, 2018. Read SEC document
May 21, 2018 Filed May 22, 2018 16:06 UTC	AETNA INC /PA/ AET · Entity 107289	Exercise / conversionCommon Stock	1,203	Not disclosed	Not disclosed	Disclosure SEC source: 0001122304-18-000095 · edgar.xml · nonDerivative · entry 1 GARTEN JEFFREY E · CIK 0001181532 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,339.533 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Units convert to Common Stock on a one-for-one basis. F2 · balance_after: Includes shares acquired through dividend reinvestment. Read SEC document
May 18, 2018 Filed May 22, 2018 16:06 UTC	AETNA INC /PA/ AET · Entity 107289	GrantRestricted Stock Units · Derivative	990	Not disclosed	Not disclosed	Disclosure SEC source: 0001122304-18-000095 · edgar.xml · derivative · entry 2 GARTEN JEFFREY E · CIK 0001181532 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 990 Underlying: Common Stock · 990 shares Expires not disclosed F1 · derivative.exercise_price: Units convert to Common Stock on a one-for-one basis. F1 · price: Units convert to Common Stock on a one-for-one basis. F3 · derivative.exercise_date: Restricted Stock Units ("Units") granted under the Aetna Inc. 2010 Non-Employee Director Compensation Plan (the "Plan"). Subject to terms of the Plan, Units will vest in four substantially equal installments on August 18, 2018, November 18, 2018, February 18, 2019, and May 18, 2019, with payment of the Units deferred until May 20, 2019. Upon payment date, Units will be issued in Common Stock. F3 · derivative.expiration_date: Restricted Stock Units ("Units") granted under the Aetna Inc. 2010 Non-Employee Director Compensation Plan (the "Plan"). Subject to terms of the Plan, Units will vest in four substantially equal installments on August 18, 2018, November 18, 2018, February 18, 2019, and May 18, 2019, with payment of the Units deferred until May 20, 2019. Upon payment date, Units will be issued in Common Stock. Read SEC document
June 29, 2017 Filed Jun 30, 2017 20:35 UTC	CARMAX INC KMX · Entity 3604	GrantCommon Stock	2,406	$0.00	$0.00	Disclosure SEC source: 0001170010-17-000110 · wf-form4_149885493902646.xml · nonDerivative · entry 1 GARTEN JEFFREY E · CIK 0001181532 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,958 F1 · shares: These are restricted shares of common stock that will vest on the one-year anniversary of the grant date. Read SEC document
May 22, 2017 Filed May 23, 2017 16:27 UTC	AETNA INC /PA/ AET · Entity 107289	Exercise / conversionRestricted Stock Units · Derivative	1,537	Not disclosed	Not disclosed	Disclosure SEC source: 0001122304-17-000056 · edgar.xml · derivative · entry 3 GARTEN JEFFREY E · CIK 0001181532 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,537 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Units convert to Common Stock on a one-for-one basis. F2 · price: Units convert to Common Stock on a one-for-one basis. F4 · derivative.exercise_date: Units granted under the Plan. Subject to terms of the Plan, Units vested in four equal installments on August 20, 2016; November 20, 2016; February 20, 2017, and May 20, 2017, with payment of the Units deferred until May 22, 2017. F4 · derivative.expiration_date: Units granted under the Plan. Subject to terms of the Plan, Units vested in four equal installments on August 20, 2016; November 20, 2016; February 20, 2017, and May 20, 2017, with payment of the Units deferred until May 22, 2017. Read SEC document
May 22, 2017 Filed May 23, 2017 16:27 UTC	AETNA INC /PA/ AET · Entity 107289	Exercise / conversionCommon Stock	1,537	Not disclosed	Not disclosed	Disclosure SEC source: 0001122304-17-000056 · edgar.xml · nonDerivative · entry 1 GARTEN JEFFREY E · CIK 0001181532 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,011.645 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Units convert to Common Stock on a one-for-one basis. F1 · balance_after: Includes shares acquired through dividend reinvestment. Read SEC document
May 19, 2017 Filed May 23, 2017 16:27 UTC	AETNA INC /PA/ AET · Entity 107289	GrantRestricted Stock Units · Derivative	1,203	Not disclosed	Not disclosed	Disclosure SEC source: 0001122304-17-000056 · edgar.xml · derivative · entry 2 GARTEN JEFFREY E · CIK 0001181532 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,203 Underlying: Common Stock · 1,203 shares Expires not disclosed F2 · derivative.exercise_price: Units convert to Common Stock on a one-for-one basis. F2 · price: Units convert to Common Stock on a one-for-one basis. F3 · derivative.exercise_date: Restricted Stock Units ("Units") granted under the Aetna Inc. 2010 Non-Employee Director Compensation Plan (the "Plan"). Subject to terms of the Plan, Units will vest in four substantially equal installments on August 19, 2017; November 19, 2017; February 19, 2018, and May 19, 2018, with payment of the Units deferred until May 21, 2018. Upon payment date, Units will be issued in Common Stock. F3 · derivative.expiration_date: Restricted Stock Units ("Units") granted under the Aetna Inc. 2010 Non-Employee Director Compensation Plan (the "Plan"). Subject to terms of the Plan, Units will vest in four substantially equal installments on August 19, 2017; November 19, 2017; February 19, 2018, and May 19, 2018, with payment of the Units deferred until May 21, 2018. Upon payment date, Units will be issued in Common Stock. Read SEC document
September 26, 2016 Filed Sep 28, 2016 20:22 UTC	CARMAX INC KMX · Entity 3604	SaleCommon Stock	6,300	$53.41	$336,483.00	Disclosure SEC source: 0001170010-16-000209 · wf-form4_147509414329154.xml · nonDerivative · entry 1 GARTEN JEFFREY E · CIK 0001181532 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,552 F1 · price: The shares with respect to this transaction were sold at prices ranging from $53.25 to $53.51. Upon request, the Reporting Person will provide the Securities and Exchange Commission staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document
September 07, 2016 Filed Sep 9, 2016 16:12 UTC	AETNA INC /PA/ AET · Entity 107289	SaleCommon Stock	7,100	$116.51	$827,213.90	Disclosure SEC source: 0001231553-16-000019 · edgar.xml · nonDerivative · entry 1 GARTEN JEFFREY E · CIK 0001181532 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,398.018 F1 · price: The price reported in Column 4 is an average sale price. These shares were sold in multiple transactions at prices ranging from $115.89 to $116.87, inclusive. F2 · balance_after: Includes units accrued under the Plan pursuant to reinvestment of dividend equivalents. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.